Biogen, Inc.
(NASDAQ : BIIB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 7.71%348.410.0%$6035.73m
ALXNAlexion Pharmaceuticals, Inc. 0.00%182.502.0%$1481.47m
NVAXNovavax, Inc. -3.28%203.0079.8%$837.30m
SNSSSunesis Pharmaceuticals, Inc. -4.57%10.640.7%$743.78m
BNTXBioNTech SE 0.44%282.220.0%$734.46m
NTLAIntellia Therapeutics, Inc. -6.90%137.682.3%$600.20m
BIIBBiogen, Inc. -0.30%325.391.7%$545.23m
AMGNAmgen, Inc. 1.18%247.621.3%$535.43m
VRTXVertex Pharmaceuticals, Inc. 2.23%200.401.9%$451.48m
REGNRegeneron Pharmaceuticals, Inc. -0.07%586.482.7%$444.11m
GILDGilead Sciences, Inc. 0.51%69.001.0%$387.16m
ILMNIllumina, Inc. 1.90%495.763.5%$276.12m
CRSPCRISPR Therapeutics AG -2.06%122.200.6%$200.74m
OCGNOcugen, Inc. -1.55%6.970.0%$164.47m
EXASEXACT Sciences Corp. -0.10%117.9118.1%$129.90m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.